Sulfacetamide
Side effects
Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ||||
| Agranulocytosis | Agranulocytosis | x | x | x | x | x | |||||||
| Aplastic anaemia | Aplastic anaemia | x | x | x | x | x | |||||||
| Blister | Blister | x | |||||||||||
| Dermatitis bullous | Blister | x | |||||||||||
| Oedema | Oedema | x | |||||||||||
| Toxic epidermal necrolysis | Toxic epidermal necrolysis | x | x | x | x | x | |||||||
| Blood disorder | Blood disorder | x | x | x | x | x | |||||||
| Hypersensitivity | Hypersensitivity | x | x | x | x | x | x | x | x | x | |||
| Systemic lupus erythematosus | Systemic lupus erythematosus | x | x | x | |||||||||
| Lupus erythematosus | x | ||||||||||||
| Pruritus | Pruritus | x | |||||||||||
| Erythema multiforme | Stevens-Johnson syndrome | x | x | x | x | x | x | x | x | x | |||
| Stevens-Johnson syndrome | Stevens-Johnson syndrome | x | x | x | x | x | x | x | x | x | |||
| Erythema | Erythema | x | |||||||||||
| Hepatic necrosis | Hepatic necrosis | x | x | x | x | x | |||||||
| Conjunctival irritation | Conjunctival irritation | x | |||||||||||
| Infection | Secondary infection | x | x | x | x | x | |||||||
| Pain | Stinging | x | x | x | x | x | x | x | |||||
| Conjunctival hyperaemia | Conjunctival hyperaemia | x | x | x | x | x | |||||||
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Color scheme:
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |
